Pages that link to "Q40506957"
Jump to navigation
Jump to search
The following pages link to Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215. (Q40506957):
Displaying 50 items.
- Drugging MYCN through an allosteric transition in Aurora kinase A (Q24303381) (← links)
- Aurora kinase-A inactivates DNA damage-induced apoptosis and spindle assembly checkpoint response functions of p73 (Q24305327) (← links)
- Phosphorylation and stabilization of HURP by Aurora-A: implication of HURP as a transforming target of Aurora-A (Q24306319) (← links)
- Aurora A, centrosome structure, and the centrosome cycle (Q24318115) (← links)
- Aurora-A phosphorylates hnRNPK and disrupts its interaction with p53 (Q24319687) (← links)
- A cancer-associated aurora A mutant is mislocalized and misregulated due to loss of interaction with TPX2 (Q24321340) (← links)
- Aurora-A Kinase as a Promising Therapeutic Target in Cancer (Q26771371) (← links)
- Aurora Kinases and Potential Medical Applications of Aurora Kinase Inhibitors: A Review (Q26783412) (← links)
- Advances in targeted therapies and new promising targets in esophageal cancer (Q26825957) (← links)
- Cell cycle progression by the repression of primary cilia formation in proliferating cells (Q27011729) (← links)
- Mdm2 and aurora kinase a inhibitors synergize to block melanoma growth by driving apoptosis and immune clearance of tumor cells (Q27347800) (← links)
- Localization and interactions of Plasmodium falciparum SWIB/MDM2 homologues (Q27974497) (← links)
- Functional Significance of Aurora Kinases-p53 Protein Family Interactions in Cancer (Q28071615) (← links)
- Cdk1, Plks, Auroras, and Neks: the mitotic bodyguards (Q28611400) (← links)
- Aurora-A interacts with AP-2α and down regulates its transcription activity (Q28741932) (← links)
- Identification of Akt interaction protein PHF20/TZP that transcriptionally regulates p53 (Q28771765) (← links)
- Regulating the p53 pathway: in vitro hypotheses, in vivo veritas (Q29615658) (← links)
- DNA-binding protects p53 from interactions with cofactors involved in transcription-independent functions (Q30392650) (← links)
- Spatial exclusivity combined with positive and negative selection of phosphorylation motifs is the basis for context-dependent mitotic signaling (Q30414432) (← links)
- Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype-negative colon cancer (Q33604452) (← links)
- Aurora kinases: novel therapy targets in cancers (Q33618929) (← links)
- Aurora kinase inhibitors--rising stars in cancer therapeutics? (Q33647643) (← links)
- A novel p53 phosphorylation site within the MDM2 ubiquitination signal: I. phosphorylation at SER269 in vivo is linked to inactivation of p53 function (Q33695618) (← links)
- Mutant TP53 posttranslational modifications: challenges and opportunities. (Q33818479) (← links)
- Occurrence of multipolar mitoses and association with Aurora-A/-B kinases and p53 mutations in aneuploid esophageal carcinoma cells (Q33864179) (← links)
- VX680/MK-0457, a potent and selective Aurora kinase inhibitor, targets both tumor and endothelial cells in clear cell renal cell carcinoma. (Q33942098) (← links)
- Control of centrin stability by Aurora A. (Q33952284) (← links)
- Cascades of transcription regulation during liver regeneration (Q34071876) (← links)
- Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2. (Q34095173) (← links)
- Update on anaplastic thyroid carcinoma: morphological, molecular, and genetic features of the most aggressive thyroid cancer (Q34152070) (← links)
- Kaposi's sarcoma herpesvirus upregulates Aurora A expression to promote p53 phosphorylation and ubiquitylation (Q34186981) (← links)
- The aurora kinases in cell cycle and leukemia (Q34203062) (← links)
- Phosphorylation and activation of androgen receptor by Aurora-A (Q34236635) (← links)
- A novel p53 phosphorylation site within the MDM2 ubiquitination signal: II. a model in which phosphorylation at SER269 induces a mutant conformation to p53 (Q34333807) (← links)
- Suppression of Aurora-A oncogenic potential by c-Myc downregulation (Q34355817) (← links)
- Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinic (Q34817365) (← links)
- Protein interaction module-assisted function X (PIMAX) approach to producing challenging proteins including hyperphosphorylated tau and active CDK5/p25 kinase complex (Q34884230) (← links)
- Issues in interpreting the in vivo activity of Aurora-A (Q34964087) (← links)
- Aurora Kinase A expression is associated with lung cancer histological-subtypes and with tumor de-differentiation. (Q35142318) (← links)
- AURKA and BRCA2 expression highly correlate with prognosis of endometrioid ovarian carcinoma (Q35154633) (← links)
- Aurora kinase A has a significant role as a therapeutic target and clinical biomarker in endometrial cancer. (Q35168142) (← links)
- Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancer. (Q35549470) (← links)
- p53 Family Members Regulate Phenotypic Response to Aurora Kinase A Inhibition in Triple-Negative Breast Cancer (Q35587605) (← links)
- Inhibition of Aurora A promotes chemosensitivity via inducing cell cycle arrest and apoptosis in cervical cancer cells. (Q35666453) (← links)
- Fibrillin-1, induced by Aurora-A but inhibited by BRCA2, promotes ovarian cancer metastasis (Q35740047) (← links)
- Aurora kinase inhibitors as anticancer molecules (Q35850203) (← links)
- Aurora-A - a guardian of poles (Q35998764) (← links)
- Aurora-A is an efficient marker for predicting poor prognosis in human nasopharyngeal carcinoma with aggressive local invasion: 208 cases with a 10-year follow-up from a single institution. (Q36084311) (← links)
- Regulation of embryonic and induced pluripotency by aurora kinase-p53 signaling (Q36145002) (← links)
- Aurora kinases: shining lights on the therapeutic horizon? (Q36210257) (← links)